CTU Bern

Track record


SWIFT-DIRECT is a multicenter, randomized controlled clinical trial to assess whether thrombectomy alone is non-inferior to intravenous alteplase plus thrombectomy for treating acute stroke patients with large vessel occlusions. Read more

HemMa Study

HemMa is a prospective cross-sectional observational study that aims to identify hematological markers in patients with sickle cell disease. The study is a collaboration between the Biologics Research Center of CSL Behring at SITEM and the Department of Hematology of the University Hospital (Inselspital) Bern. CTU Bern is involved in designing, implementing, conducting, and analyzing the study. Read more

Simpl´HIV trial

The Simpl’HIV study investigated the outcomes of virologically-suppressed patients on standard combination antiretroviral therapy (cART) switching to DTG + emtricitabine (FTC) as well as the costs of a patient-centered ART monitoring. Read more

BIOTOK Randomized Clinical Trial

Specially Designed Footwear Reduces Pain of Knee Osteoarthritis - First randomized clinical trial introduces new approach for treating the disease. Read more